Room for improvement? A quality-of-life assessment in patients with malignant bowel obstruction

Palliative Medicine

Volumn 24, Issue 1, 2010, Pages 38-45

  Selby, D ^a   Wright, F ^a   Stilos, K ^a   Daines, P ^a   Moravan, V ^a   Gill, A ^a   Chakraborty, A ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Malignant bowel obstruction; Palliative care; Quality of life

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ANOREXIA; ARTICLE; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INTESTINE OBSTRUCTION; MALE; MALIGNANT INTESTINE OBSTRUCTION; MENTAL DETERIORATION; PROSPECTIVE STUDY; QUALITY OF LIFE; SCORING SYSTEM; WELLBEING;

ABDOMINAL NEOPLASMS; ADULT; AGED; ATTITUDE TO HEALTH; FATIGUE; FEMALE; HUMANS; INTESTINAL OBSTRUCTION; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PAIN; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; STRESS, PSYCHOLOGICAL; SURVIVAL RATE; YOUNG ADULT;

EID: 75149191828     PISSN: 02692163     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269216309346544     Document Type: Article

References (31)

1. Beattie, GJ, Leonard R., Smyth JF Bowel obstruction in ovarian carcinoma: a retrospective study and review of the literature. J Palliat Care 1989 ; 3: 275-280.
2. Ripamonti C., Twycross R., Baines M., et al. Clinical-practice recommendations for the management of bowel obstruction in patients with end-stage cancer. Support Care Cancer 2001 ; 9: 223-322.
3. Feuer DJ, Broadley KE, Shepherd JH, Barton DP Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. Gynecol Oncol 1999 ; 75: 313-322.
4. Laval G., Girardier J., Lassauniere JM, Leduc B., Haond C., Schaerer R. The use of steroids in the management of inoperable intestinal obstruction in terminal cancer patients: do they remove the obstruction? Palliat Med 2000 ; 14: 3-10.
5. Mercadante S., Ferrera P., Villari P., Marrazzo A. Aggressive pharmacological treatment for reversing malignant bowel obstruction. J Pain Symptom Manage 2004 ; 28: 412-416.
6. Hardy J., Ling J., Mansi J., et al. Pitfalls in placebo-controlled trials in palliative care: dexamethasone for the palliation of malignant bowel obstruction. Palliat Med 1998 ; 12: 437-442.
7. Laval G., Arvieux C., Stefani L., Villard ML, Mestrallet JP, Cardin N. Protocol for the treatment of malignant inoperable bowel obstruction: a prospective study of 80 cases at Grenoble University Hospital Center. J Pain Symptom Manage 2006 ; 31: 502-512.
8. Legendre H., Vanhuyse F., Caroli-Bosc FX, Pector JC Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction. Eur J Sur Oncol 2001 ; 27: 364-367.
9. Blair SL, Chu DZ, Schwarz RE Outcome of palliative operations for malignant bowel obstruction in patients with peritoneal carcinomatosis from nongynecological cancer. Ann Surg Oncol 2001 ; 8: 632-637.
10. Mystakidou K., Tsilika E., Kalaidopoulou O., Chondros K., Georgaki S., Papadimitriou L. Comparison of octreotide administration vs conservative treatment in the management of inoperable bowel obstruction in patients with far advanced cancer: a randomized, double- blind, controlled clinical trial. Anticancer Res 2002 ; 22: 1187-1192.
11. Mercadante S., Ripamonti C., Casuccio A., Zecca E., Groff L. Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction. Support Care Cancer 2000 ; 8: 188-191.
12. Ripamonti C., Mercadante S., Groff L., Zecca E., De Conno F., Casuccio A. Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes: a prospective randomized trial. J Pain Symptom Manage 2000 ; 19: 23-34.
13. Shima Y., Ohtsu A., Shirao K., Sasaki Y. Clinical efficacy and safety of octreotide (SMS201-995) in terminally ill Japanese cancer patients with malignant bowel obstruction. Jpn J Clin Oncol 2008 ; 38: 354-359.
14. Yim HB, Jacobson BC, Saltzman JR, et al. Clinical outcome of the use of enteral stents for palliation of patients with malignant upper GI obstruction. Gastrointest Endosc 2001 ; 53: 329-332.
15. Gukovsky-Reicher S., Lin RM, Sial S., et al. Self-expandable metal stents in palliation of malignant gastrointestinal obstruction: review of the current literature data and 5-year experience at Harbor-UCLA Medical Center. MedGenMed 2003 ; 5: 16.
16. Okorie MI, Hussain SA, Riley PL, McCafferty IJ The use of self-expandable metal stents in the palliation of malignant bowel obstruction. Oncol Rep 2004 ; 12: 67-71.
17. Feuer DJ, Broadley KE, Shepherd JH, Barton DP Systematic review of surgery in malignant bowel obstruction in advanced gynecological and gastrointestinal cancer. The Systematic Review Steering Committee. Gynecol Oncol 1999 ; 75: 313-322.
18. Pothuri B., Meyer L., Gerardi M., Barakat RR, Chi DS Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma. Gynecol Oncol 2004 ; 95: 193-195.
19. Helyer LK, Law CH, Butler M., et al. Surgery as a bridge to palliative chemotherapy in patients with malignant bowel obstruction from colorectal cancer. Ann Surg Onc 2007 ; 14: 1264-1271.
20. Mangili G., Aletti G., Figerio M., et al. Palliative care for intestinal obstruction in recurrent ovarian cancer: a multivariate analysis. Int J Gynecol Cancer 2005 ; 15: 830-835.
21. Bruera E., Kuehn N., Miller MJ, Selmser P., Macmillan K. The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 1991 ; 7: 6-9.
22. Nekolaichuk C., Watanabe S., Beaumont C. The Edmonton Symptom Assessment System: a 15-year retrospective review of validation studies (1991-2006). Pall Med 2008 ; 22: 111-122.
23. Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer 2000 ; 88: 2164-2171.
24. Rees E., Hardy J., Ling J., Bradley K., AHern R. The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK. Palliat Med 1998 ; 12: 75-82.
25. de Haes JC, van Knippenberg FC, Neijt JP Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam Symptom Checklist. Br J Cancer 1990 ; 62: 1034-1038.
26. de Haes JCM, Olschewski M., Fayers P., et al. Measuring the quality of life of cancer patients with the Rotterdam Symptom Checklist (RSCL). A manual. The Netherlands: University of Groningen, 1996.
27. Krouse RS The international conference on malignant bowel obstruction: a meeting of the minds to advance palliative care research. J Pain Symptom Manage 2007 ; 34: S1 - S6.
28. Mularski RA, Rosenfeld K., Coons SJ, et al. Measuring outcomes in randomized prospective trials in palliative care. J Pain Symptom Manage 2007 ; 34: S7 - S19.
29. Hardy J., Edmonds P., Turner R., Rees E., AHern R. The use of the Rotterdam Symptom Checklist in palliative care. J Pain Symptom Manage 1999 ; 18: 79-84.
30. Chiarion-Sileni V., Del Bianco P., De Salvo GL, et al. Quality of life evaluation in a randomized trial of chemotherapy versus bio-chemotherapy in advanced melanoma patients. Eur J Cancer 2003 ; 39: 1577-1585.
31. Gwilliam B., Bailey C. The nature of terminal malignant bowel obstruction and its impact on patients with advanced cancer. Int J Palliat Nurs 2001 ; 7: 474-481.